000			03181nam a2200433 c 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c117783 _d117783 _x1
001			117783
003			ES-MaUEC
005			20230309093202.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200123s2019 si a o |||| 0|eng d
020			_a9789813294493
024	7		_a10.1007/978-981-32-9449-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQR177 _b2019 EB
245	0	0	_aPathogenicity and Drug Resistance of Human Pathogens _bMechanisms and Novel Approaches _cedited by Saif Hameed, Zeeshan Fatima
250			_aFirst edition
264		1	_aSingapore _bSpringer International Publishing _c2019
300			_a1 recurso en línea (XXIV, 404 páginas) _b52 ilustraciones, 43 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aModule 1_Pathogenicity and Drug resistance in Mycobacterium tuberculosis -- Module 2_ Candida infections and therapeutic strategies -- Module 3_Malarial parasite biology -- Module 4_ Emerging Viral Diseases -- Module 5_Translational Research in Human Microbes.
520	3		_aThe book comprehensively discusses the mechanisms of pathogenesis and drug resistance; current diagnostics landscape of four key human pathogens; bacterial, fungal, protozoans and viral which are the causes of major infectious diseases. It also assesses the emerging technologies for the detection and quantification of these pathogens. Further, it discusses the novel opportunities to fight against these infectious diseases and to identify pertinent drug targets with novel methodologies. It also reviews the current and future insights into the control, elimination, and eradication of these infectious diseases. Importantly, the book discusses the epidemiological characteristics and various challenges in combating Ebola and Influenza diseases. Finally, the book highlights the growing role of nanotechnology and bioinformatics resources for combating the infectious diseases. In summary, the book provides the mechanistic insight of the pathogenicity, drug-resistance, therapeutic strategies and identification of the novel drug targets of Mycobacterium tuberculosis, Plasmodium, Candida, Hepatitis C and emerging viral infections.
988			_aPrimersemestre_2020_BiomedLife
650		7	_2embne _aResistencia a los medicamentos _9146972
700	1		_aHameed, Saif _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aFatima, Zeeshan _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9789813294486
776	0	8	_iPrinted edition: _z9789813294509
776	0	8	_iPrinted edition: _z9789813294516
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-32-9449-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b02/2020 _dz _ek _zSI